[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87637]], camposKey:0014-2972 2024-01-01 Biological variability of human intraepithelial lymphocytes throughout the human gastrointestinal tract in health and coeliac disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80420]], camposKey:1742-2094 2023-12-01 Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer¿s disease and brain aging00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76112]], camposKey:1542-3565 2023-03-01 I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75336]], camposKey:2073-4409 2022-01-01 Evolutionary Origin of Insulin-Degrading Enzyme and Its Subcellular Localization and Secretion Mechanism: A Study in Microglial Cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64891]], camposKey:0014-2980 2021-01-01 Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)27083145, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52746]], camposKey:1613-4125 2020-01-01 Circulating Dendritic Cells from Celiac Disease Patients Display a Gut-Homing Profile and are Differentially Modulated by Different Gliadin-Derived Peptides00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52747]], camposKey:1078-0998 2020-01-01 Different Intraepithelial CD3+ Cell Numbers in Crohn's Disease and Ulcerative Colitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52761]], camposKey:1130-0108 2020-01-01 Duodenal lymphogram as a complementary tool in the diagnosis of celiac disease in adults00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52748]], camposKey:1130-0108 2020-01-01 Is celiac disease really associated with inflammatory bowel disease?46, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49403]], camposKey:1130-0108 2018-01-01 Recommendations to report and interpret HLA genetic findings in coeliac disease Recomendaciones para la elaboración e interpretación de informes genéticos en enfermedad celíaca458461, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3279]], camposKey:1043-4666 2017-01-01 Association of the IL-15 and IL-15Ralpha genes with celiac disease7379, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54546]], camposKey:0002-9270 2017-01-01 Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients12080, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3280]], camposKey:1753-4259 2017-01-01 New IL-15 receptor-alpha splicing variants identified in intestinal epithelial Caco-2 cells4453, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52756]], camposKey:2352-345X 2016-01-01 Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon2239, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3282]], camposKey:1756-4646 2016-01-01 Differential immunomodulatory effects of Lactobacillus rhamnosus DR20, Lactobacillus fermentum CECT 5716 and Bifidobacterium animalis subsp. lactis on monocyte-derived dendritic cells300312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3281]], camposKey:0002-9270 2016-01-01 Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients14561465, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54545]], camposKey:0210-5705 2016-01-01 Pruebas de provocación controladas en el diagnóstico diferencial
de la enfermedad celíaca2728, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3284]], camposKey:2234-943X 2015-01-01 Human colon-derived soluble factors modulate gut microbiota composition00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=5725]], camposKey:2072-6643 2015-01-01 Increased intraepithelial V alpha24 invariant NKT cells in the celiac duodenum.89608976, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2851]], camposKey:0019-2805 2014-10-01 Dendritic cell compartmentalization through the human colon67, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2872]], camposKey:1613-4125 2014-01-01 Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp11321143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2865]], camposKey:1741-7015 2014-01-01 Autoantibodies against MHC class I polypeptide-related sequence A are associated with increased risk of concomitant autoimmune diseases in celiac patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2832]], camposKey:0019-2805 2014-01-01 Effect of six strains of probiotics on the integrity of a model of intestinal epithelial monolayer2020, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2818]], camposKey:0019-2805 2014-01-01 Immunogenic effects of a new alpha-gliadin peptide on a dendritic cell culture model2525, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3285]], camposKey:1667-8982 2014-01-01 Immunological aspects of celiac disease Aspectos inmunológicos de la enfermedad celíaca738746, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2823]], camposKey:1130-0108 2014-01-01 Innate lymphoid cells and natural killer T cells in the immune system of the gastrointestinal tract334345, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2873]], camposKey:1018-4813 2014-01-01 THEMIS and PTPRK in celiac intestinal mucosa: coexpression in disease and after in vitro gliadin challenge358362, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2866]], camposKey:1932-6203 2013-01-01 Detection of Specific IgA Antibodies against a Novel Deamidated 8-Mer Gliadin Peptide in Blood Plasma Samples from Celiac Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2845]], camposKey:0019-2805 2013-01-01 Increased cytokine milieu, IgA, intraepithelial lymphocytes and CD103(-) mature DC in the human right colon compared with its left paired counterpart3939, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2837]], camposKey:0962-9351 2013-01-01 Mediators of Inflammation and Immune Responses in the Human Gastrointestinal Tract00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=21366]], camposKey:0300-5755 2013-01-01 Obtención de ingredientes funcionales innovadores naturales para el diseño de alimentos de uso específico para la salud6366, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2862]], camposKey:0301-0546 2012-01-01 Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients38, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2842]], camposKey:1130-0108 2012-01-01 Genes and populations in susceptibility to celiac disease563565, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2864]], camposKey:0014-2980 2012-01-01 IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate13371353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2859]], camposKey:0002-9270 2011-01-01 Are Non-Celiac Disease Gluten-Intolerant Patients Innate Immunity Responders to Gluten?22012201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2852]], camposKey:0036-5521 2011-01-01 IFN beta 1b induced celiac disease15251526, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2843]], camposKey:1747-4124 2011-01-01 IL-15 modulates the effect of retinoic acid, promoting inflammation rather than oral tolerance to dietary antigens315317, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2830]], camposKey:0019-2805 2011-01-01 Intestinal homeostatic signals are lost in affected areas of ulcerative colitis patients inducing an abnormal skin homing phenotype in dendritic cells and T-cells they stimulate144144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2820]], camposKey:1130-0108 2011-01-01 NOD2/CARD15 gene mutations in patients with inflammatory bowel disease in Valladolid500500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3286]], camposKey:1130-0108 2011-01-01 NOD2/CARD15 gene mutations in patients with inflammatory bowel disease in valladolid5000, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2874]], camposKey:0022-2593 2011-01-01 Revisiting genome wide association studies (GWAS) in coeliac disease: replication study in Spanish population and expression analysis of candidate genes493496, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2795]], camposKey:0301-0546 2011-01-01 Sublingual immunotherapy is safe in children, but the challenge is how to increase its efficiency?119121, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2828]], camposKey:0340-5354 2011-01-01 Value of tumour necrosis factor-alpha and interleukin 6 polymorphisms as prognostic marker of efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis149149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2858]], camposKey:0891-6934 2010-01-01 Altered expression of the lymphocyte activation antigen CD30 in active celiac disease288298, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2834]], camposKey:0210-5705 2010-01-01 Immunology of celiac disease643651, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54544]], camposKey:1578-1550 2010-01-01 Inmunología de la enfermedad celíaca: ¿qué debe saber el clínico?124128, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2829]], camposKey:0017-5749 2010-01-01 Novel mechanisms of gliadin immunotoxicity?286287, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39645]], camposKey:1521-6616 2010-01-01 The simultaneous high expression of V alpha 24, IFN-gamma and FoxP3 characterizes the liver of children with type I autoimmune hepatitis396405, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2846]], camposKey:1351-5101 2010-01-01 Value of interleukin 1 polymorphisms as prognostic marker of efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis488488, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=18300]], camposKey:0210-6523 2009-01-01 Avances en el estudio de la enfermedad celíaca281297, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2804]], camposKey:0301-0546 2009-01-01 Early infections and later allergic diseases279280, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2839]], camposKey:0301-0546 2009-01-01 From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome208215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2855]], camposKey:0962-9351 2009-01-01 High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2871]], camposKey:0017-5749 2009-01-01 Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa886887, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54547]], camposKey:0210-5705 2009-01-01 LA PRESENCIA DE AUTO-ANTICUERPOS FRENTE AL GEN A DEL CMH DE CLASE I (MICA) REPRESENTA UN FACTOR PREDICTIVO INDEPENDIENTE DE LA PRESENCIA DE ENFERMEDADES AUTOINMUNES ASOCIADAS CON LA ENFERMEDAD CELÍACA190191, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54548]], camposKey:0214-2597 2009-01-01 Luz solar, vitamina D y tuberculosis Sunlight, vitamin D and tuberculosi00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2849]], camposKey:0105-4538 2009-01-01 The profile of gliadin-degrading activity of duodenal mucosa points to a role of microflora in celiac disease366366, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3306]], camposKey:1536-4801 2008-08-01 Celiac disease pathogenesis: the proinflammatory cytokine network.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3290]], camposKey:1872-213X 2008-01-01 Allergy after inhalation and ingestion of cereals involve different allergens in allergic and celiac disease4757, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2815]], camposKey:0340-5354 2008-01-01 Anti-inflammatory cytokine gene polymorphisms in multiple sclerosis: a study in a Spanish population142142, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2869]], camposKey:0277-2116 2008-01-01 Celiac disease pathogenesis: The proinflammatory cytokine network2730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2831]], camposKey:1130-0108 2008-01-01 Changes in gen CARD15 offer a short relationship with phenotypes in Crohn's disease in the Asturias (vol 99, pg 570, 2007)740740, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3289]], camposKey:1888-4008 2008-01-01 Comparison of plasma cytokines using a multiplex technique in patients with community acquired pneumonia with or without COPD Comparación de citocinas plasmáticas en pacientes con neumonía adquirida en la comunidad con y sin diagnóstico previo de EPOC por una técnica multiplex6467, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3307]], camposKey:1177-3928 2008-01-01 Cytokine, chemokine and immune activation pathway profiles in celiac disease: An immune system activity screening by expression macroarrays00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2863]], camposKey:1521-6616 2008-01-01 Decreased circulating iNKT cell numbers in refractory coeliac disease172179, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2875]], camposKey:0269-2813 2008-01-01 Future research on coeliac disease - a position report from the European multistakeholder platform on coeliac disease (CDEUSSA)10301043, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2861]], camposKey:0009-9104 2008-01-01 Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients6473, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42089]], camposKey:1130-0108 2008-01-01 Interleukin 18 (IL-18) and other immunological parameters as markers of severity in acute pancreatitis Interleucina-18 (IL-18) y otros parámetros inmunológicos como marcadores de gravedad en la pancreatitis aguda768773, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12061]], camposKey:1130-0108 2008-01-01 (Revista Española de Enfermedades Digestivas (2007) 99, 10, (570-575))00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3287]], camposKey:1888-6116 2008-01-01 Screening for celiac disease in children genetically selected Cribado de enfermedad celíaca en población infantil genéticamente seleccionada191194, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2800]], camposKey:0300-5526 2008-01-01 Similar cytokine profiles in response to infection with respiratory syncytial virus type A and type B in the upper respiratory tract in infants112115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2867]], camposKey:1130-0108 2007-01-01 CARD 15 mutations are poorly related to Crohn's disease phenotypes in Asturias570575, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49149]], camposKey:1130-0108 2007-01-01 CARD15 mutations are poorly related to Crohn's disease phenotypes in Asturias Las mutaciones del gen CARD15 presentan escasa relación con los fenotipos de la enfermedad de Crohn en Asturias570575, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3308]], camposKey:1139-2436 2007-01-01 CTLA4+49 polymorphism in coeliac disease: An association in heterozygosis? Polimorfismo CTLA4+49 en la enfermedad celíaca: ¿ Una asociación en heterocigosis?4952, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42094]], camposKey:0025-7753 2007-01-01 Cytokines and other immunological parameters as markers of distant organ involvement in acute pancreatitis Citocinas y otros parámetros inmunológicos como marcadores de alteración de órganos a distancia en la pancreatitis aguda401406, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2847]], camposKey:0105-4538 2007-01-01 Gliadin-induced dendritic cells maturation in coeliac and non-coeliac disease individuals370370, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2856]], camposKey:0017-5749 2007-01-01 Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides889890, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2840]], camposKey:1549-1277 2007-01-01 Neuraminidase antibodies and H5N1: Geographic-dependent influenza epidemiology could determine cross-protection against emerging strains11301131, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2870]], camposKey:0091-6749 2007-01-01 Persistence of proinflarnmatory response after severe respiratory syncytial virus disease in children15471550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2838]], camposKey:1148-5493 2007-01-01 Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children162167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2822]], camposKey:0017-5749 2007-01-01 The pattern of cytokine expression determines the degree of mucosal damage441443, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3309]], camposKey:0301-0546 2006-01-01 Common variable immunodeficiency. Old questions are getting clearer263275, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3291]], camposKey:1130-5665 2006-01-01 Cost-effectiveness study of using genetic diagnosis in evaluation of celiac disease Estudio coste-efectividad de la aplicación del diagnóstico genético en la valoración de la enfermedad celíaca266272, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2825]], camposKey:0025-7753 2006-01-01 Cytokines in the pathogenesis of inflammatory bowel diseases145152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49405]], camposKey:0025-7753 2006-01-01 Cytokines in the pathogenesis of inflammatory bowel diseases Citocinas en la patogenia de la enfermedad inflamatoria intestinal145152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2868]], camposKey:0967-4845 2006-01-01 Interleukin (IL)-1 beta, IL-6 and IL-8 in nasal secretions: a common role for innate immunity in viral bronchial infection in infants?173175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49150]], camposKey:0967-4845 2006-01-01 Interleukin (IL)-1ß, IL-6 and IL-8 in nasal secretions: A common role for innate immunity in viral bronchial infection in infants?173175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2836]], camposKey:0009-9104 2006-01-01 Interleukin 18 maintains a long-standing inflammation in coeliac disease patients479485, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2860]], camposKey:0954-6111 2006-01-01 Tachyphylaxis to beta(2)-agonists in Spanish asthmatic patients could be modulated by beta(2)-adrenoceptor gene polymorphisms10721078, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2813]], camposKey:0340-5354 2006-01-01 Value of cytokine gene polymorphisms as prognostic markers of efficacy of interferon beta-1b (Betaferon (R)) in relapsing-remitting multiple sclerosis142143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12062]], camposKey:0300-9033 2005-01-01 Celiac disease. New therapeutic alternatives based on a better knowledge of molecular pathogenesis Enfermedad celíaca. Nuevas perspectivas terapéuticas basadas en un mejor conocimiento de su patogenia molecular183189, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2850]], camposKey:0025-7753 2005-01-01 Cytokines in the pathogeny of celiac disease508516, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3311]], camposKey:0301-0546 2005-01-01 IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: Differences between DQ2 positive and negative patients245249, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3310]], camposKey:0211-3465 2005-01-01 Immunomodulation strategies in celiac disease Estrategias de inmunomodulación en la enfermedad celíaca3637, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54549]], camposKey:0803-5253 2005-01-01 Interleukin-13 is involved in the survival of children with sepsis18281831, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2819]], camposKey:0002-9270 2004-01-01 Celiac disease diagnosis in patients with giardiasis: High value of antitransglutaminase antibodies13301332, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3312]], camposKey:0301-0546 2004-01-01 High cord blood IL-10 levels in preterm newborns with respiratory distress syndrome189196, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54550]], camposKey:1696-2818 2004-01-01 HLA en la enfermedad celíaca163166, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3313]], camposKey:1695-4033 2004-01-01 Meningococcal sepsis in pediatrics. Parameters associated with poor outcome Sepsis meningocócica en pediatría. Parámetros asociados a mala evolución305313, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3315]], camposKey:0211-3465 2003-01-01 Celiac disease: Genetic factors Enfermedad celíaca: Factores genéticos1720, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3314]], camposKey:1529-7535 2003-01-01 Serum procalcitonin in children with suspected sepsis: A comparison with C-reactive protein and neutrophil count190195, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2796]], camposKey:0002-9270 2002-01-01 Hypertransaminasemia in pediatric celiac disease patients and its prevalence as a diagnostic clue31763181, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3316]], camposKey:0803-5253 2002-01-01 Influence of leptin levels and body weight in survival of children with sepsis.626631, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2826]], camposKey:0140-6736 2002-01-01 One-step immunochromatographic assay for screening of coeliac disease945946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2848]], camposKey:0093-7711 2002-01-01 TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population551555, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=79103]], camposKey:1695-4033 2001-01-01 Sistema factor de necrosis tumoral y leptina en la enfermedad celíaca198204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3317]], camposKey:0302-4342 2001-01-01 The tumor necrosis factor system and leptin in coeliac disease Sistema factor de necrosis tumoral y leptina en la enfermedad celíaca198204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49406]], camposKey:0014-2972 2000-01-01 A ß-turn rich oats peptide as an antigen in an ELISA method for the screening of coeliac disease in a paediatric population702708, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2844]], camposKey:0340-6199 2000-01-01 Cord blood interleukin-10 levels are increased in preterm newborns420423, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54551]], camposKey:1131-5768 2000-01-01 Polimyalgia rheumatica without temporal artery biopsy315319, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2816]], camposKey:0093-7711 2000-01-01 The HLA-DRB4 gene is present in half of the Spanish HLA-DQ2-negative celiac patients10451046, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=79104]], camposKey:1695-4033 2000-01-01 Valor de los marcadores serológicos en el diagnóstico de la enfermedad celíaca. Propuesta de un protocolo533541, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3318]], camposKey:0302-4342 2000-01-01 Value of serological markers in the diagnosis of Celiac disease. A proposed guideline Valor de los marcadores serológicos en el diagnóstico de la enfermedad celíaca. Propuesta de un protocolo533541, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2793]], camposKey:8755-6863 1999-01-01 Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis175180, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2807]], camposKey:0905-6157 1999-01-01 Different serum interleukin-12 and sCD30 levels in food- and pollen-sensitized children235240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39649]], camposKey:0146-0404 1999-01-01 IgG subtypes in serum from patients with antisilicone antibodies (anti-S Ab).00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3319]], camposKey:0301-0546 1999-01-01 Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome1117, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2797]], camposKey:0277-2116 1998-01-01 Alpha-1 antichymotrypsin levels are actively increased in normal colostrum376379, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49407]], camposKey:0254-9670 1998-01-01 HLA-DQA1(*)0501 and DQB1(*)02 homozygosity and disease susceptibility in Spanish coeliac patients286290, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2824]], camposKey:0198-8859 1998-01-01 HLA-DQ2-negative celiac disease in Finland and Spain169175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2821]], camposKey:0905-6157 1997-01-01 Lack of correlation between soluble CD14 and IL-6 in meningococcal septic shock194199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3292]], camposKey:0302-4342 1997-01-01 Value of salivary antibodies to assess seropositivity against measles, rubella and mumps in children and adults Valor de los anticuerpos salivares para la determinacion de la seropositividad frente a sarampion, rubeola y parotiditis en ninos y adultos499504, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3293]], camposKey:0211-3465 1996-01-01 Humoral immunity in coeliac disease2427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3294]], camposKey:0302-4342 1996-01-01 Serum eosinophil cationic protein (ECP) in children with allergic and non-allergic inflammation PROTEINA CATIONICA EOSINOFILA SERICA EN NINOS CON INFLAMACION ALERGICA Y NO ALERGICA245249, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2853]], camposKey:0803-5253 1996-01-01 Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria728732, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2803]], camposKey:0065-2598 1995-01-01 Jejunal fluid antibodies and mucosal gamma/delta IEL in latent and potential coeliac disease13451348, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49408]], camposKey:0065-2598 1995-01-01 Soluble CD4 antigen is increased in activated coeliac disease13551358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2827]], camposKey:1018-9068 1995-01-01 Study of HLA-DQA1 alleles in celiac children209215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2802]], camposKey:0017-5749 1994-01-01 Intestinal antibody pattern of coeliac disease: Association with gamma-delta-T-cell receptor expression by intraepithelial lymphocytes, and other indices of potential coeliac disease476482, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49409]], camposKey:0277-2116 1993-01-01 Authors' Reply233234, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2808]], camposKey:0017-5749 1993-01-01 Clinical and pathological spectrum of coeliac disease - active, silent, latent, potential150151, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2835]], camposKey:0277-2116 1993-01-01 INCREASED SIL-2R LEVELS IN CELIAC-DISEASE - REPLY233234, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2805]], camposKey:0016-5085 1993-01-01 Intestinal antibody pattern of celiac disease: Occurrence in patients with normal jejunal biopsy histology12631272, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2812]], camposKey:0954-691X 1993-01-01 Intestinal intraepithelial lymphocytes: Whence, whither and wherefore?903906, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3295]], camposKey:0017-5749 1993-01-01 Reply17410, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59989]], camposKey:0017-5749 1993-01-01 Reply00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2811]], camposKey:0003-4738 1993-01-01 Spectrum of expression of intestinal cellular immunity: Proposal for a change in diagnostic criteria of celiac disease2932, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49410]], camposKey:0954-691X 1992-01-01 Ageing and gastrointestinal immunity114, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2806]], camposKey:0017-5749 1992-01-01 Immunosenescence and mucosal immunity: Significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts882886, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2817]], camposKey:0277-2116 1992-01-01 Increased serum IL-2R levels in coeliac disease are related to CD4 but not CD8 antigens413417, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2794]], camposKey:0017-5749 1991-01-01 Dissociation between systemic and mucosal humoral immune responses in coeliac disease2935, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3296]], camposKey:0905-6157 1991-01-01 Usefulness of antiendomysial antibodies as a serological marker in coeliac children199204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3299]], camposKey:0302-4342 1990-01-01 Celiac disease activity serological markers MARCADORES SEROLOGICOS DE ACTIVIDAD EN LA ENFERMEDAD CELIACA (EC)375376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3298]], camposKey:0302-4342 1990-01-01 Serological markers in active celiac disease Marcadores serológicos de actividad en la enfermedad celiaca (EC).564565, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3297]], camposKey:0302-4342 1990-01-01 The role of immunology in celiac disease Papel de la inmunología en la enfermedad celiaca.315324, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3300]], camposKey:0036-4355 1989-01-01 Absence of fibronectin in a 40-day-old child who died as a result of septicemia with disseminated intravascular coagulation Ausencia de fibronectina en un niño de 40 días fallecido durante una septicemia con coagulación intravascular diseminada.5962, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40020]], camposKey:0017-5749 1989-01-01 COMPARISON OF SYSTEMIC AND MUCOSAL HUMORAL IMMUNITY IN CELIAC-DISEASE00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49411]], camposKey:0301-0546 1989-01-01 IgA1, IgA2 or secretory piece containing antigliadin antibodies in the sera of coeliac patients.7780, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3301]], camposKey:0214-2880 1986-01-01 IgA-1 antigliadin antibodies are the most specific in children with coeliac disease291295, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2810]], camposKey:0301-0546 1986-01-01 Transient phenytoin induced IgA deficiency and permanent IgE increase535538][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32452]},camposKey: 375 397 El trigo como alérgeno: asma de los panaderos, alergia alimentaria y al trigo 8409041618Avances en el conocimiento de las patologías relacionadas con el gluten y evolución de los alimentos sin gluten 1 2018-01-01 Sociedad Española de Enfermedad Celíaca (SEEC) , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32533]},camposKey: 57 60 Genética, genómica, inmunología y su aplicación al tratamiento 8409041618Avances en el conocimiento de las patologías relacionadas con el gluten y evolución de los alimentos sin gluten 1 2018-01-01 Sociedad Española de Enfermedad Celíaca (SEEC) , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32531]},camposKey: 130 155 Patogenia de la enfermedad celíaca 8409041618Avances en el conocimiento de las patologías relacionadas con el gluten y evolución de los alimentos sin gluten 1 2018-01-01 Sociedad Española de Enfermedad Celíaca (SEEC) , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32532]},camposKey: 111 129 Proteínas de los cereales: Péctidos inmunoestimuladores y tóxicos 8409041618Avances en el conocimiento de las patologías relacionadas con el gluten y evolución de los alimentos sin gluten 1 2018-01-01 Sociedad Española de Enfermedad Celíaca (SEEC) , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=27966]},camposKey: 219 246 Inmunopatogenia de la enfermedad celíaca 8416270937Enfermedad celíaca 1 2016-01-01 Ergon , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19876]},camposKey: 141 162 Cereal Proteins: Immunostimulatory and Toxic Peptides 978-84-943418-2-3Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods 1 2015-01-01 Omnia Publisher, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19874]},camposKey: 163 191 Pathogenesis of Celiac Disease 978-84-943418-2-3Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods 1 2015-01-01 Omnia Publisher, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29235]},camposKey: 75 78 Preface section I. Genetics, genomics, inmunology and application to therapy 978-84-943418-2-3Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods 1 2015-01-01 Omnia Publisher, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19875]},camposKey: 462 488 Wheat as an Allergen: Baker's Asthma, Food and Wheat Pollen Allergy 978-84-943418-2-3Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods 1 2015-01-01 Omnia Publisher, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29244]},camposKey: 123 150 Immunopathogenesis of Celiac Disease 849421182XCeliac Disease and Non-Celiac Gluten Sensitivity 1 2014-11-07 OmniaScience , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19877]},camposKey: 123 149 Inmunopatogenia de la enfermedad celíaca 8494023438Enfermedad celíaca y sensibilidad al gluten no celíaca 1 2013-07-01 omnia science , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29236]},camposKey: 123 150 Inmunopatogenia de la enfermedad celíaca 8494023438Enfermedad celíaca y sensibilidad al gluten no celíaca 1 2013-07-01 omnia science , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29238]},camposKey: 201 208 Dieta sin gluten y prevención de la enfermedad celíaca 8484739589Enfermedad celíaca 1 2011-01-01 Ergon, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29749]},camposKey: 11 20 El sistema inmune del tracto digestivo y mecanismos de inflamación 8484738914Tratado de gastroenterología, hepatología y nutrición pediátrica aplicada de la SEGHNP 2 2011-01-01 Ergon , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29233]},camposKey: 177 200 Inmunopatogenia de la enfermedad celíaca 8484739589Enfermedad celíaca 1 2011-01-01 Ergon, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29237]},camposKey: 217 234 Nuevas estrategias terapéuticas 8484739589Enfermedad celíaca 1 2011-01-01 Ergon, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=330]},camposKey: 231 234 Increase in the levels of leptin in maternal serum in the postdelivery with a sparse reflex in human milk leptin levels 88-323-1924-1Perinatology 2001 1 2001-01-01 Monduzzi, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=331]},camposKey: 217 220 Lack of correlation of leptin levels in human milk and the dependent variables of new-borns 88-323-1924-1Perinatology 2001 1 2001-01-01 Monduzzi, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=329]},camposKey: 755 758 Matrix metalloproteinase-2 (MMP-2) and TIMP-1 in lung fluid of infants with Respiratory Distress Syndrome (SDR) 88-323-1924-1Perinatology 2001 1 2001-01-01 Monduzzi, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=1423]},camposKey: 40 45 Coeliac disease ISBN-0062Sixth International Conference on Squeezed States and Uncertainty Relations 1 2000-01-01 NASA, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=1421]},camposKey: 11 19 El sistema inmune del tracto digestivo y mecanismos de inflamación. ISBN-0062Sixth International Conference on Squeezed States and Uncertainty Relations 1 2000-01-01 NASA, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=1422]},camposKey: 17 30 Gluten su base estructural y bases inmunológicas de la patogenia: una visión integradora ISBN-0062Sixth International Conference on Squeezed States and Uncertainty Relations 1 2000-01-01 NASA, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=327]},camposKey: 53 59 Oral tolerance, immune expression and enteropathy: Relevance to potential, latent and silent coeliac disease 9514442938Coeliac Disease 1 1997-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=326]},camposKey: 119 127 DEFINITIONS AND DIAGNOSTIC-CRITERIA OF LATENT AND POTENTIAL CELIAC-DISEASE 3-8055-5616-0Mucosal Immunity and the Gut Epithelium 1 1995-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19844]},camposKey: 869 876 Immunological mechanisms of food allergy 9788716151612Abstracts: XVI European Congress of Allergology and Clinical Immunology : Madrid, Spain, 25-30 June 1995 1 1995-01-01 Munksgaard, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=324]},camposKey: 759 760 Secretory antibodies to gliadin in coeliac disease 978-94-010-7323-3Advances in Mucosal Immunology 1 1990-01-01 Springer, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=323]},camposKey: 467 468 Serum and salivary immunoglobulins and food antibodies in normal elderly subjects 978-94-010-7323-3Advances in Mucosal Immunology 1 1990-01-01 Springer][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=123582],camposKey=8409041618Avances en el conocimiento de las patologías relacionadas con el gluten y evolución de los alimentos sin gluten 1 2018-01-01 Sociedad Española de Enfermedad Celíaca (SEEC) }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=119658],camposKey=8416270937Enfermedad celíaca 1 2016-01-01 Ergon }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=121633],camposKey=978-84-943418-2-3Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods 1 2015-01-01 OmniaScience}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=121076],camposKey=8484739589Enfermedad celíaca 1 2011-01-01 Ergon}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=101071],camposKey=978-84-8473-958-6Enfermedad Celíaca. Introducción al conocimiento actual de la Enfermedad celíaca. 2ª edicion 1 2011-01-01 Ergon}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=123581],camposKey=8484736989Enfermedad celíaca 1 2008-01-01 Ergon}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=123908],camposKey=8484737209Enfermedad celíaca 1 2008-01-01 Ergon}][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62892]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63151]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63772]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63384]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63969]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62892]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63151]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63772]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63384]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63969]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=23]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=23]]][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=276]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=278]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=273]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30772]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637241]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637427]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637337]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637336]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636951]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633233]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145632610]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145630473]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627610]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@69a9e541, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@78fbb019, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@541c5fd4, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@51c0c924, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@77e5bdb0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@52bbb02d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@646fa751, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3331cb11, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6963e8fa, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@66d61723, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7f9a6187, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@42ce4426, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@341c50bd, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@62a52612, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4e9fe598, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7e406719, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@288f59d4, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@63516f61, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@52d3e5b6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2f56285a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7dc5959d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1587c723, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@58347e70, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@46be89d4, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@170695e3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3c13e6ff, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@47afd8f3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@75ed09fb, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@56e73328, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@75600315, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4c31350a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@510e5fa6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3e1f58dc, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4b928ca1, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@e4e69bc, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2d9ee4bc, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6983906b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@362bee7e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4bd5628e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1134c44c, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@64411ec9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@d704421, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6dd18613, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5af02941, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@36abd380, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@39f5c838, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5875300b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@394a065, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6bcb4444, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7ce8f50d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@dec77f3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2bdd69a3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1a05f1f8, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@21fe3f28, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4fc3870b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@f136f21, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3a2cd50a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6afbba18, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@39539393, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2dad99ff, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@71f58dc5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4669d299, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@63030ecc, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@22a00132, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7fe62b06, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7793c379, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@c9dc629, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2e96ef19, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@60664fd6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@987c0a8, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6b49e33f][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e6ac, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e649, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e055, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e08d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e8b1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e608, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ea20, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d8eb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e630, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e62f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e631, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3cfe, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63db7f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63da9c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e0ca, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dc19, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e8f1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63db68, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37215d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ab0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e761, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dac8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e0b2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63daa2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63deca, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dbb3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e2c5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e509, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e349][][][][][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1118]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=14]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4617f0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4662e8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@466fec], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413360], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4131c2], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412f0b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125b3], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4138a8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125e9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125e8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413f89], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41249f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412b67], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4123d7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4123c7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41230f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460795], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f45], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412236], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122a7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460704], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4605d7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f68], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5b8ce2], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f3b4], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f421], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f379], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4134b0]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16f61, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1700a, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16d57, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16b84, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@156ad, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1556e, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15203, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14e58, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@146b6, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13ec8, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@144a4, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1449d][]
